
Harness the power of AI for groundbreaking healthcare advancements. Explore insightful analytics and applications transforming the future of health.
323.6K
Similarweb

Useful as
Platforms
Pricing Model
Pricing Plans
xT CDx test
FDA-approved, next-generation sequencing (NGS)-based in vitro diagnostic device, priced at $4,500 per test.
$ 4,500
per test
xF assay
Reimbursed at $3,288 per test.
$ 3,288
per test
Discover alternative AI tools similar to Tempus that may better suit your needs.
Explore professional roles that benefit from using Tempus.